No abstract available
Keywords:
Diagnostic Tests; Fibroblast Growth Factors; Routine; cardiovascular disease; fibroblast growth factor 23; hyperphosphatemia; mineral metabolism.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Animals
-
Biomarkers / blood
-
Chronic Kidney Disease-Mineral and Bone Disorder / blood*
-
Chronic Kidney Disease-Mineral and Bone Disorder / diagnosis
-
Chronic Kidney Disease-Mineral and Bone Disorder / drug therapy
-
Chronic Kidney Disease-Mineral and Bone Disorder / physiopathology
-
Fibroblast Growth Factor-23 / blood*
-
Humans
-
Hyperparathyroidism, Secondary / blood*
-
Hyperparathyroidism, Secondary / diagnosis
-
Hyperparathyroidism, Secondary / drug therapy
-
Hyperparathyroidism, Secondary / physiopathology
-
Kidney / drug effects
-
Kidney / metabolism
-
Kidney / physiopathology*
-
Phosphorus / blood
-
Renal Agents / therapeutic use
-
Renal Insufficiency, Chronic / blood*
-
Renal Insufficiency, Chronic / diagnosis
-
Renal Insufficiency, Chronic / drug therapy
-
Renal Insufficiency, Chronic / physiopathology
-
Vitamin D / analogs & derivatives
-
Vitamin D / blood
Substances
-
Biomarkers
-
FGF23 protein, human
-
Renal Agents
-
Vitamin D
-
Phosphorus
-
1,25-dihydroxyvitamin D
-
Fibroblast Growth Factor-23